PulvinarNeuro
  • Home
  • Devices
    • First Generation Research Device
    • XCSITE-RD
  • Therapeutic Development
  • Newsroom
  • About Us

Meet New CEO: Dr. Leah Townsend, PhD

9/1/2019

0 Comments

 
We are pleased to announce that Dr. Leah Townsend, PhD has joined us as Chief Executive Officer of Pulvinar Neuro. She previously served as a business consultant for Pulvinar Neuro and was instrumental in winning our Phase I NIMH grant (R43MH119872) to develop closed-loop tACS.
​Dr. Townsend has a broad foundation in life sciences research and consulting, with over 10 years of experience in human physiology and disease pathology in addition to neurobiology. She has previous experience in both business development and life science consulting including advising life science and biotechnology clients in areas including commercial assessment and strategy, portfolio optimization, and search-based asset identification in therapeutic areas including neurology, gene therapy, stem cell therapy, oncology, bacterial infections, cardiovascular, and rare disease.
Picture
Dr. Townsend holds a PhD in Neurobiology from the University of North Carolina at Chapel Hill (UNC-CH) as well as both a BS in Psychology (summa cum laude) and BA in Philosophy (cum laude), also from UNC- CH.
0 Comments



Leave a Reply.

    Archives

    February 2023
    March 2022
    September 2019

    Categories

    All

    RSS Feed

FCOI Policy
© COPYRIGHT 2023. ALL RIGHTS RESERVED.
  • Home
  • Devices
    • First Generation Research Device
    • XCSITE-RD
  • Therapeutic Development
  • Newsroom
  • About Us